Vimarsana
Biggest News Aggregation in the World

Primary Iga News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary Iga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Iga Today - Breaking & Trending Today

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (2) - Vimarsana News

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (2)

Published: October 19, 2023

STOCKHOLM, Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX)...

Source: europapress.es
Related Topics:
United StatesStanford HealthcaredateRichard PhilipsonHong ZhangdateThierry ChristophedateNadia NawazRoisin ThomasdateJonathan BarrattRichard LafayetteAmerican Society Of NephrologyUniversity Of LeicesterdateExhibit Hallsbd Pennsylvania Convention CenterPennsylvania Convention CenterAmerican SocietyKidney WeekPrimary IgaChief Medical OfficerPresentation DetailsNefigard PhaseGlomerular DiseasesPresentation VenueBreaking Poster Presentation DetailsLate Breaking PostersExhibit Hallsb DGenetic Diseases
Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 - Vimarsana News

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Published: October 19, 2023

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven abstract presentations, including a...

Source: prnewswire.com
Related Topics:
United StatesHong ZhangRoisin ThomasRichard PhilipsonJonathan BarrattThierry ChristopheRichard LafayetteNadia NawazUniversity Of LeicesterAmerican Society Of NephrologyPennsylvania Convention CenterExhibit Hallsbd Pennsylvania Convention CenterAmerican SocietyKidney WeekPrimary IgaChief Medical OfficerPresentation DetailsNefigard PhaseGlomerular DiseasesTranslational StudiesBreaking Poster Presentation DetailsLate Breaking PostersExhibit Hallsb DGenetic DiseasesNefigard Part
Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (1) - Vimarsana News

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (1)

Published: October 19, 2023

STOCKHOLM, Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX)...

Source: europapress.es
Related Topics:
United StatesRichard PhilipsonStanford HealthcaredateHong ZhangdateThierry ChristophedateJonathan BarrattRoisin ThomasdateNadia NawazRichard LafayettePennsylvania Convention CenterExhibit Hallsbd Pennsylvania Convention CenterUniversity Of LeicesterdateAmerican Society Of NephrologyAmerican SocietyKidney WeekPrimary IgaChief Medical OfficerPresentation DetailsNefigard PhaseGlomerular DiseasesPresentation VenueBreaking Poster Presentation DetailsLate Breaking PostersExhibit Hallsb DGenetic Diseases
Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN) Tokyo 2023 - Vimarsana News

Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN) Tokyo 2023

Published: September 29, 2023

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced the presentations of new biomarker and...

Source: prnewswire.com
Related Topics:
Richard PhillipsonInternational Symposium On IgInternational Symposium On Iga Nephropathy IigaPrimary IgaInternational SymposiumIga NephropathyChief Medical OfficerFull PrescribingPrimary ImmunoglobulinInvestor RelationsCalliditas Therapeutics
Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN) - Vimarsana News

Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN)

Published: September 29, 2023

STOCKHOLM, Sept. 29, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm:...

Source: europapress.es
Related Topics:
Richard PhillipsonInternational Symposium On IgInternational Symposium On Iga Nephropathy IigaPrimary IgaInternational SymposiumIga NephropathyChief Medical OfficerFull PrescribingPrimary ImmunoglobulinInvestor Relations